Taiho Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Taiho Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Taiho Pharmaceutical Co Ltd Strategy Report
- Understand Taiho Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Taiho Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20240122937A1 | Application | Treating cancer in patient with pten inactivating mutation | A61K31/5365; A61P35/00 | April 18, 2024 |
| EP4351737A2 | Application | Behandlungsverfahren für patienten mit krebs mit einer aberration in egfr und/oder her2 | A61K31/4709; A61K31/517; A61K31/519; A61K31/537; A61P35/00; C07K16/32 | April 17, 2024 |
| EP4347041A1 | Application | Kleinmolekülige inhibitoren von kras-mutierten proteinen | A61P35/00; C07D487/04; C07D519/00 | April 10, 2024 |
| AU2019293772B2 | Grant | Antitumor agent and evaluation method thereof | A61K2039/505; A61K2039/5156; A61K2039/545; A61K2039/627; A61K2039/645; A61K2039/70; A61K2039/876; A61K2300/00; A61K38/00; A61K38/16; A61K39/0011; A61K39/001102; A61K39/00119; A61K39/395; A61K39/3955; A61K45/06; A61K47/65; A61P35/00; C07K14/4748; C07K14/70539; C07K16/2818; C07K16/2827; C07K2317/76; C12N9/90; C12Y501/03019; G01N33/5011 | April 04, 2024 |
| AU2022366515A1 | Application | Treatment methods for subjects having cancer with a dysregulated mapk and/or pi3k pathway | A61K31/519; A61P35/00 | April 04, 2024 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer